Abstract:Objective: To study the expression of IL13RA2 in gliomas and to analyze its correlation with clinicopathological/molecular features, immune cell infiltration and prognostic significance. Methods: mRNA expression data for IL13RA2 were downloaded and analyzed from two open access datasets (TCGA & CGGA). IL13RA2 protein expression was examined by immunohistochemistry. The association between IL13RA2 and important clinicopathological/molecular markers was examined using χ2 and Spearman correlation tests. The TIMER tool was used to evaluate the correlation of IL13RA2 with multiple intra-tumoral immune cell types in glioma. Kaplan-Meier test and multivariate Cox analyses were applied to evaluate the prognosis. Results: Out of the 297 glioma tissues and 20 normal brain tissues in our cohort, IL13RA2 protein was highly expressed in 115 glioma tissues (115/297, 38.7%), but no expression was detected in normal brain tissues (0/20, 0%). The expression of IL13RA2 was significantly higher in GBMs (P<0.001). More than half of GBMs (68/132, 51.5%) were high expression of IL13RA2 protein, especially GBM patients with IDH wild-type and TERT promoter mutated (60/78, 76.9%). Moreover, 11/13 (84.6%) diffuse midline gliomas and 31/51 (64.7%) IDH wild-type LGGs also highly expressed IL13RA2 in our cohorts. Chi-square test showed that the expression of IL13RA2 was correlated with patient age, WHO grade, Ki67 index, IDH status, TERT promoter status and immune cell infiltration. Additionally, IL13RA2 was strongly associated with patients' OS and served as a negative prognostic marker in infiltrating gliomas. Conclusion: IL13RA2 was high expression in some glioma subtypes, and significantly correlated with poor prognosis. Based on its role in CAR-T therapy, it might act as an extremely important and specific therapeutic target for human malignant gliomas, especially in IDH wild-type LGG, "IDH wild-type and TERT promoter mutated" GBM and H3K27M-mutated diffuse midline glioma, and improve the clinical outcomes of these patients.

IL13RA2 promotes progression of infantile haemangioma by activating glycolysis and the Wnt/β-catenin signaling pathway

A novel hsa_circ_0006903 circular RNA promotes tumor development and dendritic cells activated expression in infantile hemangioma

LncRNA-TUG1 promotes the progression of infantile hemangioma by regulating miR-137/IGFBP5 axis

Macrophages Contribute to the Progression of Infantile Hemangioma by Regulating the Proliferation and Differentiation of Hemangioma Stem Cells.

IL13RA2 is overexpressed in malignant gliomas and related to clinical outcome of patients

Identifying Potential Diagnostic and Therapeutic Targets for Infantile Hemangioma Using WGCNA and Machine Learning Algorithms

Knockdown of IGF2R Suppresses Proliferation and Induces Apoptosis in Hemangioma Cells in Vitro and in Vivo.

Non-coding RNA in infantile hemangioma

Signaling pathways in the development of infantile hemangioma

Identification of Potential Therapeutics for Infantile Hemangioma via in silico Investigation and in vitro Validation

Long Noncoding RNA Expression Profile of Infantile Hemangioma Identified by Microarray Analysis

Targeting ESM1 via SOX4 promotes the progression of infantile hemangioma through the PI3K/AKT signaling pathway

868 Hypoxia Induced Cyr61 Productions Involved in the Pathogenesis of Infantile Hemangioma

MiR-206 Promotes Extracellular Matrix Accumulation and Relieves Infantile Hemangioma Through Targeted Inhibition of DNMT3A

CENPF May Act as a Novel Marker and Highlight the Influence of Pericyte in Infantile Hemangioma

Integrated WGCNA and PPI Network to Screen Hub Genes Signatures for Infantile Hemangioma

Silencing long non‑coding RNA NEAT1 suppresses the tumorigenesis of infantile hemangioma by competitively binding miR‑33a‑5p to stimulate HIF1α/NF‑κB pathway

Role Of Endothelial-Mesenchymal Transition In The Tumorigenesis Of Infantile Hemangioma

Silencing of IL13RA2 Promotes Partial Epithelial‐mesenchymal Transition in Hepatocellular Carcinoma Via ERK Signaling Pathway Activation

Identification of Novel Potential Biomarkers in Infantile Hemangioma Via Weighted Gene Co-Expression Network Analysis

Exosome-derived Mir-196B-5p Facilitates Intercellular Interaction in Infantile Hemangioma Via Down-Regulating CDKN1B